Controlling Molecules From Tea to Advanced Bioreactors

Deniz Kent, CEO of Prolific Machines, shares his journey of raising over $90M from top-tier investors, including Series B+ rounds.

What this short covers

Deniz Kent, CEO of Prolific Machines, shares his journey of raising over $90M from top-tier investors, including Series B+ rounds. He discusses his strategies for securing capital and his company's pivot from cultured meat to therapeutic proteins.

Transcript

So traditionally we'll use molecules when you add in the molecule. This is my uh my tea here. It's my scale down bioreactor. You know if I'm imagining I add the milk to my tea and you watch the milk dissolve. You can't control where the milk goes. And you also can't control when it goes where it goes. It's just going to it's going to do what it does and it'll move stochastically. Um, that's a problem in a bioreactor if you want to, for example, have something switch on and then something switch off and then a different thing switch on and then switch off, which you frequently want to do. You want to be able to toggle multiple things in order to make stuff. Um, that's really hard to do with things that move around randomly. And if you want to create patterns, it's also very hard to do that with molecules that move around randomly. Uh, because your patterns are going to be random. But

frequently we don't want random patterns.

Series B+ guides to read next

All Series B+ guides

More fundraising shorts (216)

Fundraising videos (423)

Library · Fundraising articles A–Z · Pitch deck guides

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades